Molecular characterization and distribution of Schistosoma cercariae collected from naturally infected bulinid snails in northern and central Côte d'Ivoire.

Bulinus forskalii Bulinus globosus Bulinus truncatus Côte d’Ivoire Molecular markers Schistosoma bovis Schistosoma haematobium Schistosome hybrids

Journal

Parasites & vectors
ISSN: 1756-3305
Titre abrégé: Parasit Vectors
Pays: England
ID NLM: 101462774

Informations de publication

Date de publication:
19 Mar 2019
Historique:
received: 07 11 2018
accepted: 06 03 2019
entrez: 21 3 2019
pubmed: 21 3 2019
medline: 24 4 2019
Statut: epublish

Résumé

Accurate identification of schistosome species infecting intermediate host snails is important for understanding parasite transmission, schistosomiasis control and elimination. Cercariae emerging from infected snails cannot be precisely identified morphologically to the species level. We used molecular tools to clarify the distribution of the Schistosoma haematobium group species infecting bulinid snails in a large part of Côte d'Ivoire and confirmed the presence of interspecific hybrid schistosomes. Between June 2016 and March 2017, Bulinus snails were sampled in 164 human-water contact sites from 22 villages of the northern and central parts of Côte d'Ivoire. Multi-locus genetic analysis (mitochondrial cox1 and nuclear ITS) was performed on individual schistosome cercariae shed from snails, in the morning and in the afternoon, for species and hybrid identification. Overall, 1923 Bulinus truncatus, 255 Bulinus globosus and 1424 Bulinus forskalii were obtained. Among 2417 Bulinus screened, 25 specimens (18 B. truncatus and seven B. globosus) shed schistosomes, with up to 14% infection prevalence per site and time point. Globally, infection rates per time point ranged between 0.6 and 4%. Schistosoma bovis, S. haematobium and S. bovis × S. haematobium hybrids infected 0.5%, 0.2% and 0.4% of the snails screened, respectively. Schistosoma bovis and hybrids were more prevalent in B. truncatus, whereas S. haematobium and hybrid infections were more prevalent in B. globosus. Schistosoma bovis-infected Bulinus were predominantly found in northern sites, while S. haematobium and hybrid infected snails were mainly found in central parts of Côte d'Ivoire. The data highlight the necessity of using molecular tools to identify and understand which schistosome species are transmitted by specific intermediate host snails. The study deepens our understanding of the epidemiology and transmission dynamics of S. haematobium and S. bovis in Côte d'Ivoire and provides the first conclusive evidence for the transmission of S. haematobium × S. bovis hybrids in this West African country. Trial registration ISRCTN, ISRCTN10926858. Registered 21 December 2016; retrospectively registered (see: http://www.isrctn.com/ISRCTN10926858 ).

Sections du résumé

BACKGROUND BACKGROUND
Accurate identification of schistosome species infecting intermediate host snails is important for understanding parasite transmission, schistosomiasis control and elimination. Cercariae emerging from infected snails cannot be precisely identified morphologically to the species level. We used molecular tools to clarify the distribution of the Schistosoma haematobium group species infecting bulinid snails in a large part of Côte d'Ivoire and confirmed the presence of interspecific hybrid schistosomes.
METHODS METHODS
Between June 2016 and March 2017, Bulinus snails were sampled in 164 human-water contact sites from 22 villages of the northern and central parts of Côte d'Ivoire. Multi-locus genetic analysis (mitochondrial cox1 and nuclear ITS) was performed on individual schistosome cercariae shed from snails, in the morning and in the afternoon, for species and hybrid identification.
RESULTS RESULTS
Overall, 1923 Bulinus truncatus, 255 Bulinus globosus and 1424 Bulinus forskalii were obtained. Among 2417 Bulinus screened, 25 specimens (18 B. truncatus and seven B. globosus) shed schistosomes, with up to 14% infection prevalence per site and time point. Globally, infection rates per time point ranged between 0.6 and 4%. Schistosoma bovis, S. haematobium and S. bovis × S. haematobium hybrids infected 0.5%, 0.2% and 0.4% of the snails screened, respectively. Schistosoma bovis and hybrids were more prevalent in B. truncatus, whereas S. haematobium and hybrid infections were more prevalent in B. globosus. Schistosoma bovis-infected Bulinus were predominantly found in northern sites, while S. haematobium and hybrid infected snails were mainly found in central parts of Côte d'Ivoire.
CONCLUSIONS CONCLUSIONS
The data highlight the necessity of using molecular tools to identify and understand which schistosome species are transmitted by specific intermediate host snails. The study deepens our understanding of the epidemiology and transmission dynamics of S. haematobium and S. bovis in Côte d'Ivoire and provides the first conclusive evidence for the transmission of S. haematobium × S. bovis hybrids in this West African country. Trial registration ISRCTN, ISRCTN10926858. Registered 21 December 2016; retrospectively registered (see: http://www.isrctn.com/ISRCTN10926858 ).

Identifiants

pubmed: 30890180
doi: 10.1186/s13071-019-3381-3
pii: 10.1186/s13071-019-3381-3
pmc: PMC6423847
doi:

Banques de données

ISRCTN
['ISRCTN10926858']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Bill & Melinda Gates Foundation
ID : OPP50816

Références

Parasitology. 2001;123 Suppl:S245-60
pubmed: 11769287
Parasitology. 2003 Sep;127(Pt 3):231-42
pubmed: 12964826
J Parasitol. 2006 Feb;92(1):77-88
pubmed: 16629320
Adv Parasitol. 2006;61:567-622
pubmed: 16735173
Trends Parasitol. 2006 Dec;22(12):575-82
pubmed: 17030017
Parasit Vectors. 2008 Jun 10;1(1):15
pubmed: 18544153
J Helminthol. 2009 Mar;83(1):33-8
pubmed: 18922204
J Helminthol. 2010 Mar;84(1):107-14
pubmed: 19646307
Acta Trop. 1990 Feb;47(2):101-14
pubmed: 1969699
PLoS Pathog. 2009 Sep;5(9):e1000571
pubmed: 19730700
Acta Trop. 2013 Nov;128(2):423-40
pubmed: 22580511
Parasit Vectors. 2012 Sep 03;5:185
pubmed: 22943137
PLoS Negl Trop Dis. 2012;6(10):e1882
pubmed: 23145200
Heredity (Edinb). 2013 May;110(5):466-74
pubmed: 23321708
PLoS Negl Trop Dis. 2013 Apr 04;7(4):e2110
pubmed: 23593513
Trends Parasitol. 2013 Sep;29(9):449-59
pubmed: 23849836
Lancet. 2014 Jun 28;383(9936):2253-64
pubmed: 24698483
Adv Parasitol. 2015 Apr;88:123-64
pubmed: 25911367
Acta Trop. 2015 Sep;149:179-85
pubmed: 26004285
Parasit Vectors. 2015 Aug 07;8:410
pubmed: 26246374
Parasitol Res. 2015 Nov;114(11):4127-33
pubmed: 26268566
Parasit Vectors. 2015 Aug 20;8:432
pubmed: 26329827
PLoS Pathog. 2015 Sep 03;11(9):e1005098
pubmed: 26336070
Parasitology. 2017 Jan;144(1):65-80
pubmed: 27572906
Emerg Infect Dis. 2016 Dec;22(12):2212-2214
pubmed: 27869609
Clin Infect Dis. 2016 Dec 15;63(12):1626-1629
pubmed: 27941144
Infect Dis Poverty. 2017 May 4;6(1):93
pubmed: 28468667
BMC Public Health. 2018 Jan 29;18(1):186
pubmed: 29378542
Parasitology. 2018 Nov;145(13):1727-1731
pubmed: 30086805
Acta Trop. 1984 Jun;41(2):181-202
pubmed: 6206702
Mol Mar Biol Biotechnol. 1994 Oct;3(5):294-9
pubmed: 7881515
Int J Parasitol. 1994 Apr;24(2):285-90
pubmed: 8026909
J Helminthol. 1993 Dec;67(4):259-64
pubmed: 8132969
Heredity (Edinb). 1993 Jan;70 ( Pt 1):33-7
pubmed: 8432659
Acta Trop. 1997 Jun 24;66(1):35-44
pubmed: 9177094
Parasitology. 1998 Aug;117 ( Pt 2):117-22
pubmed: 9778633

Auteurs

Yves-Nathan T Tian-Bi (YT)

Unité de Formation et de Recherche Biosciences, Université Félix Houphouët-Boigny, 22 BP 770, Abidjan 22, Côte d'Ivoire.
Centre Suisse de Recherches Scientifiques en Côte d'Ivoire, 01 BP 1303, Abidjan 01, Côte d'Ivoire.

Bonnie Webster (B)

Wolfson Wellcome Biomedical Laboratories, Department of Life Sciences, Natural History Museum, Cromwell Road, London, SW7 5BD, UK. b.webster@nhm.ac.uk.

Cyrille K Konan (CK)

Unité de Formation et de Recherche Biosciences, Université Félix Houphouët-Boigny, 22 BP 770, Abidjan 22, Côte d'Ivoire.
Centre Suisse de Recherches Scientifiques en Côte d'Ivoire, 01 BP 1303, Abidjan 01, Côte d'Ivoire.

Fiona Allan (F)

Wolfson Wellcome Biomedical Laboratories, Department of Life Sciences, Natural History Museum, Cromwell Road, London, SW7 5BD, UK.

Nana R Diakité (NR)

Unité de Formation et de Recherche Biosciences, Université Félix Houphouët-Boigny, 22 BP 770, Abidjan 22, Côte d'Ivoire.
Centre Suisse de Recherches Scientifiques en Côte d'Ivoire, 01 BP 1303, Abidjan 01, Côte d'Ivoire.

Mamadou Ouattara (M)

Unité de Formation et de Recherche Biosciences, Université Félix Houphouët-Boigny, 22 BP 770, Abidjan 22, Côte d'Ivoire.
Centre Suisse de Recherches Scientifiques en Côte d'Ivoire, 01 BP 1303, Abidjan 01, Côte d'Ivoire.

Diabaté Salia (D)

Centre d'Entomologie Médicale et Vétérinaire, Université Alassane Ouattara de Bouaké, 27 BP 529, Abidjan 27, Côte d'Ivoire.

Amani Koné (A)

Institut National d'Hygiène Publique, Ministère de la Santé et de l'Hygiène Publique, Boulevard Du Port (Chu)-Treichville, Bp V 14, Abidjan, Côte d'Ivoire.

Adolphe K Kakou (AK)

Institut National d'Hygiène Publique, Ministère de la Santé et de l'Hygiène Publique, Boulevard Du Port (Chu)-Treichville, Bp V 14, Abidjan, Côte d'Ivoire.

Muriel Rabone (M)

Wolfson Wellcome Biomedical Laboratories, Department of Life Sciences, Natural History Museum, Cromwell Road, London, SW7 5BD, UK.

Jean T Coulibaly (JT)

Unité de Formation et de Recherche Biosciences, Université Félix Houphouët-Boigny, 22 BP 770, Abidjan 22, Côte d'Ivoire.
Centre Suisse de Recherches Scientifiques en Côte d'Ivoire, 01 BP 1303, Abidjan 01, Côte d'Ivoire.
Swiss Tropical and Public Health Institute, P.O. Box, CH-4002, Basel, Switzerland.
University of Basel, P.O. Box, CH-4003, Basel, Switzerland.

Stefanie Knopp (S)

Swiss Tropical and Public Health Institute, P.O. Box, CH-4002, Basel, Switzerland.
University of Basel, P.O. Box, CH-4003, Basel, Switzerland.

Aboulaye Meïté (A)

Programme National de Lutte contre les Maladies Tropicales Négligées à Chimiothérapie Préventive (PNLMTN-CP), Ministère de la Santé et de l'Hygiène Publique, 06 BP 6394, Abidjan 06, Côte d'Ivoire.

Jürg Utzinger (J)

Swiss Tropical and Public Health Institute, P.O. Box, CH-4002, Basel, Switzerland.
University of Basel, P.O. Box, CH-4003, Basel, Switzerland.

Eliézer K N'Goran (EK)

Unité de Formation et de Recherche Biosciences, Université Félix Houphouët-Boigny, 22 BP 770, Abidjan 22, Côte d'Ivoire.
Centre Suisse de Recherches Scientifiques en Côte d'Ivoire, 01 BP 1303, Abidjan 01, Côte d'Ivoire.

David Rollinson (D)

Wolfson Wellcome Biomedical Laboratories, Department of Life Sciences, Natural History Museum, Cromwell Road, London, SW7 5BD, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH